Reaction

Thrombophlebitis Superficial reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,040 reports · 104 co-occurring drugs

As of the last recalculation, Thrombophlebitis Superficial appears in 3,040 FAERS reports alongside 104 co-occurring drug terms. The strongest observed disproportionality signal is DROSPIRENONE AND ETHINYL ESTRADIOL (PRR 203.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Drospirenone And Ethinyl Estradiol	919	203.6	208.0
Etonogestrel And Ethinyl Estradiol	147	47.6	48.0
Iron Sucrose	43	31.3	31.4
Ibuprofen And Diphenhydramine Citrate	81	24.5	24.5
Testosterone Cypionate	24	18.5	18.6
Cephalexin	49	15.7	15.8
Rizatriptan Benzoate	21	14.2	14.3
Promethazine Hydrochloride	38	14.2	14.2
Meperidine Hydrochloride	15	11.2	11.2
Cefazolin Sodium	18	10.3	10.3
Drs. Clotrimazole	17	10.1	10.1
Family Wellness Clotrimazole	17	10.1	10.1
Clotrimazole Topical	17	10.1	10.1
Clotrimazole	18	10.1	10.1
Testosterone	34	10.1	10.1
Minocycline	17	10.0	10.0
Temozolomide	28	9.2	9.2
Mometasone	23	8.6	8.7
Ciprofloxacin Hydrochloride And Hydrocortisone	26	8.6	8.6
Fondaparinux Sodium	10	8.5	8.5
Cefazolin	11	8.3	8.3
Sucralfate Oral	17	8.2	8.2
Sucralfate Oral Suspension	17	8.2	8.2
Mupirocin	16	8.2	8.2
Docusate Sodium - Sennosides	38	8.2	8.2
Amoxicillin And Clavulanate Potassium	32	8.1	8.1
Erythromycin	22	8.1	8.1
Mupirocin Calcium	16	8.0	8.0
Quinine	10	8.0	8.0
Carisoprodol	22	7.9	8.0
Ketoconazole Foam	17	7.9	7.9
Ketoconazole Cream, 2%	17	7.9	7.9
Oseltamivir	9	7.8	7.8
Tretinoin	9	7.6	7.6
Diphenoxylate Hydrochloride And Atropine Sulfate	15	7.5	7.5
Azithromycin Dihydrate	62	7.4	7.4
Azithromycin	42	7.2	7.2
Ketoconazole	18	7.2	7.2
Raloxifene Hydrochloride	15	7.1	7.1
Ibuprofen	258	7.0	7.0
Fluconazole	69	6.9	6.9
Azithromycin Monohydrate	41	6.8	6.8
Enoxaparin Sodium	55	6.6	6.7
Dalteparin Sodium	10	6.5	6.5
Polyethylene Glycol	10	6.3	6.3
Sucralfate	22	6.3	6.3
Ibuprofen Tablets, Coated	38	6.2	6.2
Ibuprofen Sodium	38	6.1	6.1
Octreotide Acetate	27	6.1	6.1
Clindamycin Phosphate	29	6.0	6.0
Cetirizine Hcl	8	6.0	6.0
Naproxen	66	5.9	5.9
Nitrofurantoin	14	5.8	5.8
Nitrofurantoin (Monohydrate/Macrocrystals)	14	5.8	5.8
Baricitinib	8	5.7	5.7
Ibuprofen Capsule	156	5.6	5.6
Ibuprofen Tablet, Film Coated	156	5.6	5.6
Ibupfrofen	156	5.6	5.6
Ibuprofen Tablets Usp, 200Mg	156	5.6	5.6
Ibuprofen Oral	156	5.6	5.6
Ibuprofen Capsules 200 Mg	156	5.6	5.6
Ibuprofen 200 Mg	156	5.6	5.6
Ibuprofen 200Mg	156	5.6	5.6
Meclizine Hcl 12.5Mg	11	5.5	5.5
Meclizine Hcl 25Mg	11	5.5	5.5
Meclizine Hcl 12.5 Mg	11	5.5	5.5
Meclizine Hcl 25 Mg	11	5.5	5.5
Romiplostim	12	5.5	5.5
Mometasone Furoate	33	5.5	5.5
Sulfamethoxazole And Trimethoprim	65	5.4	5.4
Oxycodone Hydrochloride And Acetaminophen	75	5.3	5.3
Sumatriptan	29	5.3	5.3
Fexofenadine	12	5.0	5.0
Extended Phenytoin Sodium	12	4.9	4.9
Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl	35	4.8	4.8
Naproxen Sodium	97	4.8	4.8
Heparin Sodium	9	4.5	4.5
Multivitamin	32	4.4	4.4
Ziprasidone Mesylate	9	4.3	4.3
Polatuzumab Vedotin	6	4.2	4.2
Naproxen Sodium Tablet	32	4.2	4.2
Rivaroxaban	122	4.1	4.1
Triamcinolone Acetonide Ointment Usp, 0.05%	14	4.1	4.1
Oseltamivir Phosphate	14	3.9	3.9
Ziprasidone	10	3.9	3.9
Loratadine Tablet	30	3.9	3.9
Eszopiclone	14	3.8	3.8
Carfilzomib	15	3.6	3.6
Conjugated Estrogens And Medroxyprogesterone Acetate	12	3.5	3.5
Loratadine And Pseudoephedrine Sulfate	4	3.4	3.4
Timolol	6	3.4	3.4
Fluticasone Propionate And Salmeterol	19	3.1	3.1
Medroxyprogesterone Acetate	21	2.9	2.9
Bendamustine Hydrochloride	5	2.9	2.9
Gemcitabine Hydrochloride	22	2.9	2.9
Lenalidomide	167	2.8	2.8
Eltrombopag Olamine	8	2.4	2.4
Alpelisib	3	2.4	2.4
Dabigatran Etexilate Mesylate	22	2.1	2.1
Pomalidomide	26	1.7	1.7
Emicizumab	3	1.7	1.7
Etonogestrel	10	1.4	1.4
Levonorgestrel	27	0.9	0.9
Adapalene	4	0.1	0.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.